# Arnuity Ellipta

NDC: 0173-0874
Generic name: fluticasone furoate
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER
Routes: RESPIRATORY (INHALATION)
Marketing started: 20140820

FDA application: NDA205625

## Active ingredients

- FLUTICASONE FUROATE: 100 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0874"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0874
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50f193ee-1691-486d-9370-a664df63695c